Nci
Nci funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)
A 2027 NIH cooperative agreement opportunity for U.S. academic community oncology organizations to build regional trial accrual infrastructure and strengthen cancer prevention, treatment, and care delivery research across affiliated community hospitals and clinics.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00, Independent Basic Experimental Studies with Humans Required)
NIH K99/R00 parent-track career transition award for mentored early-stage postdocs proposing independent basic experimental studies with humans, with recurring submission windows into 2027.
NIH RFA-CA-27-020: Advanced Development of Informatics Technologies for Cancer Research and Management (U24)
RFA-CA-27-020 invites advanced development and dissemination of mature cancer informatics technologies through a U24 cooperative agreement, with NCI committing approximately $2.6M in FY2027 for about three awards and a maximum direct cost of $600,000 per project year.
PA-25-172: Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional), 2026-2027
An NCI parent R01 notice for population-level cancer research, cancer control science, and implementation-focused projects with recurring submission cycles through the 2027 cycle.
RFA-CA-24-026: National Cancer Institute Youth Enjoy Science Research Education Program (R25)
NIH R25 funding for institutions that design middle-school to undergraduate cancer research education programs, requiring research experiences, curriculum/method development, and outreach.
RFA-CA-27-006: NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
A federal clinical-research cooperative agreement for US institutions to serve as NCORP research hubs that run cancer prevention, treatment, symptom-management, and care-delivery trials in community settings.
RFA-CA-27-016: The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)
NIH/NCI’s ETCTN NOFO seeks institutions that can lead early-phase cancer therapeutic trials within the NCI Cancer Therapy Evaluation Program, using the UM1 cooperative agreement model with a strong focus on trial activation, accrual, and mentorship for early career investigators.
RFA-CA-27-021: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
NCI’s RFA-CA-27-021 supports advanced and widely adopted cancer informatics resources through U24 sustained-support awards, with $1.8 million committed in FY 2027 across two awards.